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Abstract
Background: Gamma (γ)-Aminobutyric acid (GABA) as a bioactive compound is used extensively in functional
foods, pharmaceuticals and agro-industry. It can be biosynthesized via decarboxylation of monosodium glutamate
(MSG) or L-glutamic acid (L-Glu) by glutamate decarboxylase (GAD; EC4.1.1.15). GADs have been identified from a
variety of microbial sources, such as Escherichia coli and lactic acid bacteria. However, no GADs from Streptomyces
have been characterized. The present study is aimed to identify new GADs from Streptomyces strains and establish
an efficient bioproduction platform for GABA in E. coli using these enzymes.
Results: By sequencing and analyzing the genomes of three Streptomyces strains, three putative GADs were
discovered, including StGAD from Streptomyces toxytricini NRRL 15443, SsGAD from Streptomyces sp. MJ654-NF4 and
ScGAD from Streptomyces chromofuscus ATCC 49982. The corresponding genes were cloned from these strains and
heterologously expressed in E. coli BL21(DE3). The purified GAD proteins showed a similar molecular mass to GadB
from E. coli BL21(DE3). The optimal reaction temperature is 37 °C for all three enzymes, while the optimum pH
values for StGAD, SsGAD and ScGAD are 5.2, 3.8 and 4.2, respectively. The kinetic parameters including Vmax, Km, kcat
and kcat/Km values were investigated and calculated through in vitro reactions. SsGAD and ScGAD showed high
biocatalytic efficiency with kcat/Km values of 0.62 and 1.21 mM− 1·s− 1, respectively. In addition, engineered E. coli
strains harboring StGAD, SsGAD and ScGAD were used as whole-cell biocatalysts for production of GABA from LGlu. E. coli/SsGAD showed the highest capability of GABA production. The cells were repeatedly used for 10 times,
with an accumulated yield of 2.771 kg/L and an average molar conversion rate of 67% within 20 h.
Conclusions: Three new GADs have been functionally characterized from Streptomyces, among which two showed
higher catalytic efficiency than previously reported GADs. Engineered E. coli harboring SsGAD provides a promising
cost-effective bioconversion system for industrial production of GABA.
Keywords: Glutamate decarboxylase, γ-Aminobutyric acid, Streptomyces, Heterologous expression, Whole-cell
biotransformation
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Background
Gamma (γ)-Aminobutyric acid (GABA), also named
4-aminobutyric
acid,
is
a
non-proteinogenic
water-soluble amino acid generally existing in various
animal brains, plants and bacteria [1]. GABA considered
as one of inhibitory neurotransmitters has been applied
extensively to functional foods, pharmaceuticals and
agro-industry due to its various biological activities such
as hypotensive, epilepsy treatment, asthma control, sleep
and memory improvement, hormone-regulating and
obesity-preventing effects [2]. 2-Pyrrolidone was reported to be applied to chemically synthesize GABA,
which composed the linear polymer compound named
as nylon 4, a biodegradable plastic material [3]. As illustrated in Fig. 1, GABA is biosynthesized in the cells
through decarboxylation of L-glutamate catalyzed by
glutamate decarboxylase (GAD; EC4.1.1.15) [4, 5].
GAD is a pyridoxal 5′-phosphate (PLP)-dependent
intracellular enzyme widely distributed in various biogenetic resources [6]. Most reported natural GADs exhibit their higher catalytic capacity under acidic
conditions, and the crystal structure of E. coli GAD revealed the molecular mechanism to some extent [7–9].
The optimal catalysis pH values of bacterial GADs were
reported to be in the range from 3.8 to 4.6 [10]. Obviously, this catalytic property of GAD was adverse to the
industrial scale bio-manufacture of GABA on account of
the cost of desalination process. There are numerous
genetically engineered microorganisms reported to possess higher activity in basic conditions and enhanced
GABA yield [11]. To date, GABA was mainly synthesized from MSG or L-Glu by applying the purified GAD
enzyme or whole-cell/resting-cell biocatalysts [10]. The
whole-cell bioconversion exhibits obvious superiority
to the catalysis with purified enzyme because of its
great efficiency, relatively easy preparation and low
costs. Thus, it has been widely applied in industrial
scale production of valuable compounds [12]. GAD
has also been used in the early diagnosis of type I
diabetes. GADs have been isolated from various microbial sources for industrial purposes, such as E. coli,
lactic acid bacteria (LAB), Streptococcus salivarius,
Bacillus megaterium, Pyrococcus horikoshii, Aspergillus
oryzae and Neurospora crassa [4].
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Streptomyces is rich in natural products with various
biological activities, such as antibacterial, antiviral,
anti-cholesterol, antiprotozoan and antitumor properties
[13]. As a result, Streptomyces is well studied for natural
product discovery and biosynthesis. However, GADs
from this genus have never characterized. Therefore, it is
of interest to explore this untapped source for new
GADs and reveal their potential in GABA production.
In this work, we sequenced and analyzed the genomes of
three Streptomyces species including Streptomyces toxytricini NRRL 15443, Streptomyces sp. MJ654-NF4 and
Streptomyces chromofuscus ATCC 49982. Each strain
was found to harbor a putative gad gene, including Stgad
from S. toxytricini, Ssgad from Streptomyces sp. and
Scgad from S. chromofuscus. We cloned these three gad
genes from the corresponding hosts and expressed them
in E. coli BL21(DE3). Recombinant StGAD, SsGAD and
ScGAD were purified using Ni-NTA chromatography
for enzymatic studies. These enzymes were functionally
characterized as L-glutamate decarboxylase and their enzymatic properties were also investigated. SsGAD and
ScGAD showed higher efficiency than previously reported GADs, with kcat/Km values of 0.62 and 1.21 mM−
1 −1
·s , respectively. Finally, we tested the capability of
engineered E. coli BL21(DE3) strains harboring StGAD,
SsGAD and ScGAD for GABA production. E. coli/
SsGAD showed the best performance as whole-cell biocatalyst and gave an accumulated GABA yield of 2.771
kg/L after repeated use for 10 times. This work provides
an efficient biosynthetic platform for industrial production of GABA.

Results
Amino acid sequence analysis of three putative GADs
from Streptomyces

We have sequenced the genomes of S. toxytricini NRRL
15443, Streptomyces sp. MJ654-NF4, and S. chromofuscus
ATCC 49982 [14, 15]. Analysis of these genomes revealed that each of these three Streptomyces strains contains a putative GAD gene. Based on the Latin names of
the strains, these putative genes were named Stgad,
Ssgad and Scgad, respectively. BLAST analysis of the
amino acid sequences of these GADs indicated that they
shared 53% or lower identities with previously reported

Fig. 1 GABA production from L-glutamate by glutamate decarboxylase (GAD) with pyridoxal-5′-phosphate (PLP) as a cofactor
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Table 1 Identities of StGAD, SsGAD and ScGAD with known GADs
Known GADs

Streptomyces GADs
StGAD

References
SsGAD

ScGAD

48%

46%

Identities
Escherichia coli BL21(DE3) GadB

50%

[25]

Escherichia coli BL21(DE3) GadA

50%

48%

46%

[25]

Bacillus cereus ATCC 10876 GAD

52%

52%

53%

[24]

Listeria monocytogenes GAD

48%

46%

45%

[22]

Lactobacillus brevis CGMCC 1306 GAD

48%

44%

46%

[20]

Lactococcus lactis subsp.cremoris MG1363 GAD

45%

45%

47%

[23]

Lactobacillus plantarum Taj-Apis362 GAD

47%

44%

48%

[21]

GADs listed in Table 1. All these three putative GADs
contain the amino acid residues GI(V/S) TY(F)D(T)G
(245–250, numbering according to the sequence of
ScGAD) conserved for the catalytic site of GADs [16,
17] in Additional file 1: Figure S1. The amino acid residues HV(I)DG(A) ASGG (276–283) are highly conserved in PLP-dependent decarboxylases, such as the
GAD from Lactobacillus brevis CGMCC 1306 [18, 19].
In addition, the IN(S) T(V/A)SGHKYGLV(A)YPGVGWV(A)L(V/I)WR (307–327) motif is a PLP binding domain, in which the conserved lysine residue (K313) was
indicated to be an active site for binding of PLP [16, 19].
Moreover, this lysine residue is essential for GAD decarboxylation, formation of aldimine, hydrolysis and
product release. Therefore, the sequence analysis suggested that StGAD, ScGAD and SsGAD are functional
GADs. A phylogenetic tree was built for the three Streptomyces GADs and several reported GADs, including
Lactobacillus brevis CGMCC 1306 GAD [20], Lactobacillus plantarum Taj-Apis362 GAD [21], Listeria monocytogenes GAD [22], Lactococcus lactis subsp.cremoris
MG1363 GAD [23], Bacillus cereus ATCC 10876 GAD
[24], Escherichia coli BL21(DE3) GadB [25], and Escherichia coli BL21(DE3) GadA [25]. As shown in Fig. 2, all

three Streptomyces GADs form their own clades that are
different from those reported GADs. StGAD is in one
clade, while SsGAD and ScGAD are relatively similar
and were grouped into another clade.
Overexpression and purification of recombinant StGAD,
SsGAD, ScGAD and GadB

In order to functionally characterize these putative
GADs, we next attempted to express these enzymes in
E. coli BL21(DE3). GadB is a well characterized GAD
from E. coli and thus was used as a reference enzyme for
comparison. These genes were cloned from the genome
of the hosts and ligated into pET28a. The resulting plasmids, including pHW1 (pET28a-GadB), pHW4
(pET28a-StGAD), pHY1 (pET28a-ScGAD) and pHY6
(pET28a-SsGAD), were expressed in E. coli BL21(DE3).
SDS-PAGE analysis (Fig. 3a) showed that all proteins
(52–56 kDa) can be expressed in this strain. The calculated molecular weights were 53 kDa for StGAD, 54.7
kDa for SsGAD, 56.3 kDa for ScGAD and 52.7 kDa for
GadB. Notably, StGAD, SsGAD and GadB were
expressed well at 28 °C, while more soluble ScGAD was
produced in E. coli at 18 °C than 28 °C. These four His6-tagged GADs were purified by Ni-NTA affinity

Fig. 2 Phylogenetic tree of GADs. The GAD sequences used include StGAD, ScGAD, SsGAD, Lactobacillus brevis CGMCC 1306 GAD, Lactobacillus
plantarum Taj-Apis362 GAD, Listeria monocytogenes GAD, Lactococcus lactis subsp. cremoris MG1363 GAD, Bacillus cereus ATCC 10876 GAD,
Escherichia coli BL21(DE3) GadB, and Escherichia coli BL21(DE3) GadA
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Fig. 3 SDS-PAGE analysis of expression and purification of GADs from E. coli BL21(DE3). a Expression of GadB, StGAD, ScGAD, and SsGAD in E. coli
BL21(DE3). M: protein ladder; 1 and 2: insoluble and soluble fractions of E. coli BL21(DE3)/pET28a (vector control); 3 and 4: soluble and insoluble
fractions of E. coli BL21(DE3)/GadB; 5 and 6: soluble and insoluble fractions of E. coli BL21(DE3)/StGAD; 7 and 8: soluble and insoluble fractions of
E. coli BL21(DE3)/SsGAD; 9 and 10: soluble and insoluble fractions of E. coli BL21(DE3)/ScGAD. b GADs purified from the engineered E. coli
BL21(DE3) strains. 1: GadB; 2: StGAD; 3: SsGAD; 4: ScGAD. StGAD, SsGAD and GadB were expressed in E. coli BL21(DE3) at 28 °C, while ScGAD was
expressed at 18 °C. The target band of the GADs are in the green box

chromatography to homogeneity (Fig. 3b) for the following enzymatic studies. The isolation yields of GadB,
StGAD, SsGAD and ScGAD were 60.5 ± 2.5, 33.1 ± 1.7,
50.0 ± 3.2 and 20.5 ± 2.4 mg/L, respectively.

the highest conversion rate, which was 68-fold and
1.7-fold of those of StGAD and GadB, respectively. Similarly, SsGAD showed around 60-fold and 1.5-fold stronger catalytic activity than those of StGAD and GadB.

Functional identification of three Streptomyces GADs

Determination of the kinetic parameters of the three
Streptomyces GADs

The purified GADs were subjected to in vitro reactions
using monosodium glutamate (MSG) as the substrate,
with GadB from E. coli as the positive control. All the
three GADs were found to be able to convert MSG to
GABA, confirming that they are indeed L-glutamate
decarboxylases. GAD requires proton participation to
perform the glutamate decarboxylation reaction [26].
The optimum pH of bacterial GADs has been reported
to be in the range of 4.0–5.0 [19, 27, 28]. The activity of
the three Streptomyces GADs were tested at 37 °C and
different pH values ranging from 2.6 to 6.0. The
optimum activity of StGAD, SsGAD, and ScGAD was
observed at pH 5.2, 3.8, and 4.2, respectively (Fig. 4a).
These were different from the characterized GadB for
which the optimum pH value is 4 [27].
We then tested the activity of StGAD, SsGAD, and
ScGAD at five different reaction temperatures including
18, 28, 37, 50 and 60 °C. Interestingly, the optimal
temperature for all three GADs were found to be 37 °C
(Fig. 4b). The three purified GADs exhibited significantly
different catalytic efficiency (p < 0.05). ScGAD exhibited

To understand the properties and catalytic efficiency
of the three Streptomyces GADs, the Km, Vmax and
kcat values of StGAD, SsGAD, ScGAD and GadB
were measured using MSG as the substrate and were
calculated from corresponding Lineweaver-Burk plots
in Fig. 4c. The Km values for StGAD, SsGAD ScGAD
and GadB were 7.67 ± 0.55, 35.17 ± 2.12, 23.25 ± 2.07,
and 35.83 ± 2.40 mM, respectively (Table 2), indicating that these enzymes have different affinity to
MSG. The Vmax values for StGAD, SsGAD and
ScGAD were determined to be 0.226 ± 0.01, 23.42 ±
1.57 and 29.94 ± 2.16 μmol·min− 1·mg− 1, respectively.
Among the three Streptomyces GADs, ScGAD was
found to possess the highest efficiency, with a kcat/
Km value of 1.21 ± 0.09 mM− 1·s− 1. SsGAD showed a
kcat/Km value of 0.62 ± 0.04 mM− 1·s− 1, whereas
StGAD is the least efficient, with a low kcat/Km of
0.026 ± 0.003 mM− 1·s − 1 (Table 2). The kcat/Km
values of SsGAD and ScGAD are much higher than
GadB, which is 0.31 ± 0.02 mM− 1·s − 1. Therefore,
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Fig. 4 Enzymatic properties of StGAD, SsGAD, ScGAD and GadB. a Effect of the reaction pH on GAD activity; b Effect of the reaction temperature
on GAD activity; c Determination of the kinetic parameters via the Lineweaver-Burk plot

SsGAD and ScGAD are more efficient than those
previously reported GADs [20, 28, 29].
Bioconversion of MSG and L-Glu into GABA using
engineered E. coli as a whole-cell biocatalyst

MSG and L-glutamic acid (L-Glu) were respectively used
as substrates to generate GABA. The engineered E. coli
strain harboring StGAD, SsGAD or ScGAD was utilized
as a whole-cell biocatalyst for GABA production. E. coli
BL21(DE3)/GadB was used for comparison and wild
type E. coli BL21(DE3) (WT) was used as the control.
Previous studies reported that E. coli GAD showed its
full activity at about pH 4–5 [1, 30]. Therefore, we conducted the whole-cell biotransformation reactions in 0.1
M sodium acetate buffer at pH 4.6. We also tested the
same reactions in water only. The OD600 value of the

cells in the biotransformation system was 20. Conversion
of 2 M MSG or L-Glu was conducted at 37 °C for 1 h.
As shown in Fig. 5a, the four engineered E. coli strains
had exponentially higher yields of GABA than the wild
type. Among these engineering strains, E. coli
BL21(DE3)/SsGAD showed the best performance, and
the yields of GABA from L-Glu reached 1366 ± 102 mM
in the sodium acetate buffer and 1319 ± 116 mM in
water in one single-batch reaction (Fig. 5a). However,
when MSG was used as the substrate, even for E. coli
BL21(DE3)/SsGAD as the best catalyst, only 14.2 ± 1.0
mM and 5.9 ± 0.3 mM GABA was obtained in the sodium acetate buffer and in water. It was observed that
L-Glu was preferred by all these GAD-harboring E. coli
strains, and the yields from L-Glu were much higher
than those from MSG (p < 0.05) in both the sodium

Table 2 Kinetic parameters for StGAD, SsGAD, ScGAD and GadB
Kinetic parameters

Streptomyces GADs
StGAD

Vmax (μmol·min− 1·mg− 1)

0.226 ± 0.01d
c

Km (mM)

7.67 ± 0.55

kcat (s− 1)

0.20 ± 0.02d
−1 −1

kcat/Km (mM ·s )

GadB
SsGAD

d

0.026 ± 0.003

ScGAD

23.42 ± 1.57b

29.94 ± 2.16a

12.53 ± 0.72c

a

35.17 ± 2.12

b

23.25 ± 2.07

35.83 ± 2.40a

21.96 ± 2.08b

28.08 ± 1.99a

11.00 ± 0.88c

b

0.62 ± 0.04

a

1.21 ± 0.09

0.31 ± 0.02c

Data are shown as the mean ± standard deviation (n = 3). The different letters indicate significant differences among samples at a significant level of 0.05 (p <
0.05), and the same letters indicate no significant differences
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Fig. 5 GABA production by whole-cell biocatalysis with enigneered E. coli strains. (a) Bioconversion of 2 M MSG/L-Glu to GABA in the sodium
acetate buffer (pH 4.6) and water; (b) Effect of L-Glu concentration on GABA production. Conversions were performed at 37 °C for 1 h with a cell
density of OD600 20 and PLP concentratin of 0.2 mM in water. Data are shown as the mean ± standard deviation (n = 3). The different letters
indicate significant differences among samples at a significant level of 0.05 (p < 0.05), and the same letters indicate no significant differences

acetate buffer and water. For example, the yield of GABA
by E. coli/SsGAD from L-Glu was 170-fold higher than
that of MSG. Moreover, there was almost no significant
difference between GABA production in the sodium
acetate buffer and water when L-Glu was taken as the
substrate (Fig. 5a). Therefore, we used L-Glu as the substrate and water as the reaction system for the following
whole-cell bioconversion studies.
E. coli BL21(DE3)/StGAD, E. coli BL21(DE3)/SsGAD,
E. coli BL21(DE3)/ScGAD, and E. coli BL21(DE3)/GadB
were then reacted with different concentrations of L-Glu
(1–7 M) in water. When the substrate concentration was

lower than 4 M, the GABA production efficiency was
high for all strains, with yields of 1.5–2.4 M and molar
conversion rates of 77.4–88.5% within 1 h (Fig. 5b).
However, when the L-Glu concentration was higher, the
conversion efficiency decreased. When 7 M of L-Glu was
added, the conversion ratio was reduced to 24.9–28.0
mol%. The reaction mixture system cannot be mixed
well with shaking due to large amounts of insoluble
L-Glu in the system, which might have impacted the reaction efficiency. Additionally, high concentrations of
GABA might also inhibit the reaction. Overall, the recombinant E. coli strain harboring SsGAD exhibited a
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conversion capability superior to StGAD, ScGAD and
GadB (Figs. 5a and b). Thus, this strain was chosen for
the following whole-cell bioconversion studies.
Effects of cell and PLP concentrations on GABA
production

The effects of cell amount and PLP concentration on
GABA yield were evaluated with E. coli BL21(DE3)/
SsGAD. We first tested the reactions of this strain at different cell concentrations ranging from OD600 2 to 32,
with 7 M L-Glu at 37 °C for 2 h (Fig. 6a). The L-Glu concentration was set the highest concentration of 7 M to
ensure that the substrate is enough for the high cell concentrations. It was found that the conversion rate increased with higher concentrations of cells. OD600 20
showed the highest conversion rate, with a yield of 3.3
M. Further increase in cell concentration did not yield
more product, likely due to a too dense reaction system.
PLP is an essential cofactor for GAD-catalyzed decarboxylation of L-Glu [4]. Various concentrations of
PLP were then tested with E. coli BL21(DE3)/SsGAD
at OD600 20. The reactions were performed at 37 °C
for 2 h with 4 M L-Glu. Our results showed that
GABA yield reached 3335 ± 75 mM with the enhancement of PLP supplementation up to 0.2 M (Fig. 6b).
Further increase in the PLP concentration did not
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increase the production of GABA. This result agrees
with those of GADs from E. coli NBRC 3806 and
Lactobacillus brevis HYE1 [17, 31].

GABA production of GABA from L-Glu by repeated use of
E. coli BL21(DE3)/SsGAD

We next tested whether E. coli BL21(DE3)/SsGAD can
be repeatedly used for GABA production, which can reduce the production costs of GABA. The reaction time
was first investigated with different concentrations of
L-Glu with the cell concentration being OD600 20. When
the concentration of L-Glu was 1 M, it took 2 h to reach
92 mol% conversion. However, it took a longer time to
reach the highest conversion rate for 2, 3 and 4 M L-Glu
(Fig. 6c). In addition, the velocity in the first hour
reached the highest for all the reactions and slowed
down after 1 h. At the first reaction hour, GABA was
produced at 736 ± 52 mM (73.6 mol%, molar conversion
ratio), 1410 ± 101 mM (70.5 mol%), 1907 ± 127 mM
(63.6 mol%) and 2155 ± 177 mM (53.9 mol%) from 1, 2,
3 and 4 M L-Glu, respectively. Based on the GABA yield
and productivity, 2 M L-Glu supplementation was selected for batch reactions (Fig. 6d).
For batch reactions, a cell density of OD600 20 was
used. The initial concentration of L-Glu was 2 M and

Fig. 6 Optimization of GABA production by E. coli BL21(DE3)/SsGAD from L-Glu. a Effect of the cell concentration on GABA yield. The reactions
were performed with 7 M L-Glu in water at 37 °C for 2 h and with a cell density of OD600 20; b Effect of the PLP concentration on GABA yield. The
reaction was carried out at 37 °C for 2 h with 4 M L-Glu and a cell density of OD600 20 in water. c Time course analysis of GABA formation in
single-batch reactions with 1 M, 2 M, 3 M, and 4 M L-Glu. The concentrations of cells and PLP were OD600 20 and 0.2 mM, respectively; d Batch
reactions with reused E. coli BL21(DE3)/SsGAD with a cell density of OD600 20
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PLP was supplemented at 0.2 mM. The bioconversion
was performed at 37 °C for 1 h before an additional 2 M
L-Glu was added into reaction system. The cells were
then centrifuged and re-used for the next batch. We
found that E. coli BL21(DE3)/SsGAD can be used for at
least 10 batches with a conversion rate of 57–77 mol%
(Fig. 6d). The accumulated yield of GABA in one liter of
reaction system was 26.9 mol (equal to 2.771 kg) of
GABA from a total of 40 mol (equal to 5.885 kg) of
L-Glu. This is higher than previously reported 614.15 g/
L [1, 3, 4, 11]. The overall molar conversion rate and
productivity were about 67% within 20 h and 138 g/L/h,
respectively. Therefore, E. coli BL21(DE3)/SsGAD is a
promising strain for GABA production.

Discussion
GAD is a PLP-dependent decarboxylase which specifically converts L-Glu into GABA. GABA attracted large
interests in its industrial promise, thus, new GADs with
higher decarboxylation efficiency is primary and critical
to develop cost-effective GABA biosynthetic process. Although Streptomyces strains have been well explored for
physiologically active compounds, characterization of
GADs from this genus has never been reported. In this
work, we identified three new GADs from three different
Streptomyces strains. The function and catalytic activity
of StGAD, SsGAD and ScGAD were tested and confirmed with reactions using pure enzymes or cells expressing these GADs.
PLP is an essential cofactor for the efficient interactions between GAD and substrate [32]. The internal
aldimine was formed to link PLP and the active-site residue K279 of L. brevis CGMCC 1306 GAD, and they catalyzed the decarboxylation reaction through the
formation of this kind of Schiff base. Several other
amino acid residues, including Ser126, Ser127, Ser276,
Ser321, Cys66, Ile206 and His278 in L. brevis CGMCC
1306 GAD, were reported to be critical in the orientation of PLP and promotion of decarboxylation reaction
[19]. Hence, PLP seems to be necessary for decarboxylation reactions of GADs in vitro. However, for
whole-cell biotransformation, PLP is not required because of its natural occurrence in E. coli cells. In this
work, the GABA yield was increased by 45% with 0.05
mM PLP addition compared to that of without PLP
addition (Fig. 6b). When the amount of PLP was over
0.2 mM, GABA production did not increase further. In
addition, PLP biosynthetic genes, pdxS and pdxT from
Bacillus subtilis, have been reported to be successfully
introduced into lysine decarboxylase-overexpressing E.
coli strain BL-CadA without exogenous PLP requirement
[33]. The crystal structure of Lactobacillus brevis
CGMCC 1306 GAD indicated that a putative substrate
pocket containing Lys 279, Thr 64, Thr 205, Phe 65, Phe
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334, Cys 66, Gln 166, and Ser 321 and a flexible loop including residues YLGGE (308–312) played the critical
role on decarboxylation of L-Glu. The amino acid residue differences among StGAD, SsGAD, and ScGAD
could contribute to their significant variations on Km
and kcat/Km shown in Table 2.
MSG was utilized as the substrate to determine the
kinetic parameters of GadB, StGAD, SsGAD and ScGAD
in the in vitro reactions because of its high water solubility (~ 740 g/L). In terms of GABA production with
whole-cell biotransformation, reactions with MSG and
L-Glu as the substrate exhibited significantly different
productivity, which was attributed to GAD’s acidic
pH-dependent property. Microbial origin GADs could
become inactive at pH values above 6 due to conformational changes [34]. MSG is basic in water and L-Glu is
acidic. The pH value was gradually increased (5.6 ± 0.2/
6.88 ± 0.1, 5.9 ± 0.1/6.98 ± 0.2, 6.1 ± 0.2/7.09 ± 0.1, and
6.3 ± 0.3/7.26 ± 0.3) when MSG was supplemented into
0.1 M of sodium acetate buffer (pH 4.6)/water at 1 M, 2
M, 3 M and 4 M because of the alpha-amino group, respectively, which makes a disadvantageous pH environment for the catalytic activity of GADs [35].
Accordingly, MSG is not a suitable substrate for GABA
production using whole cells. High concentration of
MSG in the reaction system increases the pH and osmotic pressure, which have harmful impacts on the decarboxylation reaction and the cells, respectively.
Alternatively, L-Glu is a better substrate to biosynthesize
GABA on account of maintaining the acidic pH condition, as shown in some previous studies [3, 11, 31].
Thus, in this study, we used L-Glu as the substrate to
achieve a favorable acidic pH environment for GABA
production. L-Glu has much lower solubility in water
than MSG, around 7.5 g per liter of water at 20 °C. As a
result, the majority of L-Glu in the reaction system was
in solid form and it can be continuously dissolved into
water as the conversion proceeds [12]. Correspondingly,
much higher yields of GABA were obtained from L-Glu
than MSG (Fig. 5a), supporting that L-Glu is a better
substrate for GABA production using whole cells.
The whole-cell or resting cell biocatalysis has a lot of
advantages over in vitro enzymatic reactions because of
the simple production process, high efficiency and low
costs. Although ScGAD showed a higher kcat/Km value
than SsGAD (1.21 vs 0.62 mM− 1·s− 1) (Table 2), E. coli
BL21(DE3)/SsGAD performed better than the strain harboring ScGAD. This is likely due to the lower expression
level of ScGAD than SsGAD (20.5 vs 50 mg/L) in E. coli.
The resting cells of E. coli/GADs could be reused unless
they are disrupted, resulting in the release of intracellular GAD out of cells and inactivation/degradation. In
our work, the engineered E. coli cells with SsGAD is a
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promising candidate for an economically viable industrial scale production of GABA.

Conclusions
In conclusion, we discovered three putative GAD genes
from the genomes of S. toxytricini NRRL 15443, Streptomyces sp. MJ654-NF4, and S. chromofuscus ATCC
49982. These GADs, including StGAD, SsGAD, and
ScGAD, were cloned and heterologously expressed in E.
coli BL21(DE3). The functions of these enzymes were
characterized. StGAD, SsGAD, and ScGAD showed different enzymatic characteristics, and the catalytic efficiencies were different among the GADs from different
Streptomyces strains. The kcat/Km values of SsGAD and
ScGAD are higher than previously reported GADs. An
efficient whole-cell biocatalyst was developed from
SsGAD to produce GABA in a cost-effective manner. In
view of GABA production, engineered E. coli
BL21(DE3)/SsGAD cells could be used for at least ten
batches with an overall conversion rate of 67%. The accumulated GABA yield reached 2.771 kg from 5.885 kg
L-Glu in one liter of reaction system. Thus, this engineered strain has potential applications for industrial
production of GABA as a highly efficient biocatalyst.

Methods
Strains, plasmids and media

E. coli XL1-Blue was used for general cloning purposes.
E. coli BL21(DE3) was used for GAD expression and
GABA production. The pJET1.2 and pET28a (+) vectors
were used for cloning and expression, respectively. Phusion DNA polymerase, restriction enzymes and T4 DNA
ligase were purchased from New England Biolabs. All
primers were synthesized by Sigma-Aldrich. E. coli
strains were routinely cultivated in Luria-Bertani (LB)
medium (Fisher Scientific, USA) at 37 °C. Carbenicillin
and kanamycin were used at 50 μg/mL as needed for selection of correct clones. All chemicals were of analytical
grade and purchased from Fisher Scientific.
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Cloning of gad genes from Streptomyces and plasmid
construction

Three gad genes from S. toxytricini NRRL 15443
(StGAD, GenBank accession number MK303594), Streptomyces sp. MJ654-NF4 (SsGAD, GenBank accession
number MK303595), S. chromofuscus ATCC 49982
(ScGAD, GenBank accession number MK303596) and
gadB from E. coli BL21(DE3) (GenBank accession number ACT43333) were PCR amplified using primers listed
in Table 3. The PCR reactions were performed using the
following touchdown conditions: initial denaturation at
98 °C for 5 min, followed by 20 cycles of denaturation
(98 °C for 30 s), annealing (75 °C with 0.5 °C decrease in
each cycle for 30 s), and elongation (72 °C for 2 min),
then followed by 20 additional cycles of denaturation
(98 °C for 30 s), annealing (65 °C for 30 s), and elongation
(72 °C for 2 min), with a final extension at 72 °C for 10
min. The resultant 1395-bp Stgad, 1401-bp Ssgad,
1437-bp Scgad and 1401-bp gadB products were ligated
into the pJET1.2 cloning vector, yielding pHW3, pHY15,
pHY10 and pHW2 (Table 4). The first three plasmids
were digested with NdeI and HindIII, and pHY2 that
contains gadB was digested with NdeI and XhoI for verification. These gad genes were excised from the
pJET1.2-derived plasmids and ligated into the pET28a
(+) vector to yield pHW4, pHY6, pHY1 and pHW1
(Table 4), respectively. To confirm the sequences, these
pET28a (+)-derived plasmids were then sent out for sequencing using the Sanger method.
Expression of StGAD, SsGAD, ScGAD and GadB in E. coli
BL21(DE3) and enzyme purification

E. coli BL21(DE3) harboring pHW4, pHY6, pHY1 and
pHW1 were grown at 37 °C with shaking at 250 rpm in
3 mL of LB medium containing kanamycin (50 μg/mL)
for about 12 h. The seed cultures were respectively transferred to 100 mL of LB broth containing kanamycin (50 μg/
mL) with shaking at 250 rpm at 37 °C until the OD600 value
reached 0.4–0.6. Isopropyl β-D-1-thiogalactopyranoside
(IPTG) was added at a final concentration of 200 μM to induce GAD expression. The cultures were incubated for an

Table 3 Primers for amplifying the GAD genes from E. coli and Streptomyces
Gene

Primers

Restriction site

gadB

Forward: 5′-CGCCATATGGATAAGAAGCAAGTAACG-3′

NdeI

Reverse: 5′-CCCTCGAGTCAGGTATGTTTAAAGCTGTT-3′

XhoI

Stgad

Ssgad

Scgad

The restriction sites are underlined

Forward: 5′-AACATATGGCTCTCCACAAGACGAAGGA-3′

NdeI

Reverse: 5′-AAAAGCTTTTAGTGGTGGAAGCCGGAGCGGGGA-3′

HindIII

Forward: 5′-AACATATGGCCTTGTACAAGGGCACCG-3′

NdeI

Reverse: 5′-AAAAGCTTTTAGTGGTGGAAGCCGGCGCGGACC-3′

HindIII

Forward: 5′-AACATATGCCACTCCACCAAGGCGCGGACA-3′

NdeI

Reverse: 5′-AAAGCTTTTAGTGGTGGAAGGCGGTGGCGGCC-3′

HindIII
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Table 4 List of plasmids used in this work
Plasmids

Description

Source

pHW2

gadB in pJET1.2

This Work

pHW1

gadB in pET28a

This Work

pHW3

Stgad in pJET1.2

This Work

pHW4

Stgad in pET28a

This Work

pHY10

Scgad in pJET1.2

This Work

pHY1

Scgad in pET28a

This Work

pHY15

Ssgad in pJET1.2

This Work

pHY6

Ssgad in pET28a

This Work

additional 16 h at 28 °C (pHW4, pHY6, pHW1) or 18 °C
(pHY1) with shaking at 250 rpm before harvest. After centrifugation at 12,000×g for 10 min at 4 °C, the cell pellets
were re-suspended in the lysis buffer (20 mM Tris–HCl,
0.5 M NaCl, pH 7.9) with 1 mM dithiothreitol and disrupted by ultrasonication (Misonix Sonicator 3000, Misonix
Inc., USA) on ice. The cell lysates were centrifuged at
12,000×g for 10 min. The supernatants were collected and
analyzed by SDS-PAGE as soluble fractions. Cell debris
were dissolved in 8 M urea solution and analyzed on
SDS-PAGE as insoluble fractions.
To purify recombinant StGAD, SsGAD, ScGAD, and
GadB, the supernatants from the cell lysates were loaded
on a HisPur™ Ni-NTA affinity column (Thermo Scientific,
Rockford, USA). After washing column with cold wash
buffer (50 mM Tris-Hcl, 2 mM EDTA, 20 mM imidazole,
pH 7.9), the recombinant StGAD, SsGAD, ScGAD, and
GadB proteins were finally eluted with elution buffer (50
mM Tris-Hcl, 2 mM EDTA, 250 mM imidazole, pH 7.9).
The fractions were concentrated and desalted using the
30 K Macrosep Advance Centrifugal Device (Pall Corporation, New York, USA). The protein concentrations were
determined using the Bradford assay [36]. These enzymes
were stored in 50% glycerol (v/v) at − 20 °C.
Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) analysis of protein expression

SDS-PAGE was performed using 12% separation gel, 4%
stacking gel, and Laemmli’s Tris-glycine electrolyte buffer system at pH 8.3 on a discontinuous vertical slab
electrophoresis system [6]. The standard marker was the
BLUEstain™ protein ladder obtained from Gold Biotechnology Inc. (St. Louis, MO, USA) with a molecular
weight range of 11–245 kDa. After electrophoresis, the
gel was stained with 0.1% Coomassie brilliant blue R-250
and destained with 12–15% acetic acid in water (v/v).
Enzymatic activity assay and quantification of GABA
formation

The activities of StGAD, SsGAD, ScGAD and GadB
were examined through in vitro reactions based on the
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Berthelot method with some modifications [3, 37]. The
2.0-mL reaction mixture consisted of 200 mM Na2HPO4-citric acid buffer (pH 5.2 for StGAD, pH 3.8 for
SsGAD, pH 4.2 for ScGAD and pH 4.0 for GadB), 50
mM L-MSG, 0.01 mM PLP, and 50–100 μL of purified
enzyme. The mixtures were thoroughly mixed and incubated at 37 °C for 30 min and then inactivated by boiling
for 5 min. The reaction mixtures were centrifuged, and
supernatants were collected for measurement of GABA
using the Berthelot reaction method. The Berthelot reaction was carried out with a total volume of 2.5 mL which
was composed of 1.0 mL of reaction sample, 500 μL of
H2O, 100 μL of 200 mM sodium borate (pH 9.0), and
500 μL of 6% phenol and 400 μL of 5% (w/v) sodium
hypochlorite. The mixtures were thoroughly mixed,
boiled for 10 min, and then immediately placed on ice
bath for 20 min. GABA concentration was calculated by
measuring the absorbance at 630 nm. 4-Aminobutyric
acid (Acros Organics, New Jersey, USA) was used as
standard.
Investigation of reaction conditions and kinetic
parameters for the recombinant GADs
Optimum pH and temperature assay

The effect of pH on the activity of the recombinant
GADs was determined using 200 mM Na2HPO4-citric
acid buffer at various pH values (2.6–6.0) at 37 °C for 30
min. The effect of temperature on GAD activity was
measured by incubating the enzymes at the optimum
pH value for 30 min at different temperatures (18 °C –
60 °C). Subsequently, the formation of GABA in each reaction was quantified and compared.
Determination of kinetic parameters of GADs

The kinetic parameters were estimated through in vitro
reactions containing different MSG concentrations from
5 mM to 100 mM, 0.01 mM PLP, 200 mM Na2HPO4-citric acid buffer with corresponding optimum pH value,
and 50–100 μL of purified enzyme. The Km and Vmax
values were estimated by using double reciprocal via the
Lineweaver-Burk plot [17]. The kcat and kcat/Km were
then calculated.
Whole-cell bioconversion process

After induction for 16 h at 28 °C or 18 °C, wild type E.
coli BL21(DE3) and the engineered strains harboring
StGAD, SsGAD, ScGAD and GadB were collected by
centrifugation at 12,000×g for 20 min and then resuspended in the 0.1 M sodium acetate buffer at pH 4.6 or
water with MSG or L-Glu as the substrate at appropriate
concentrations. Cell density was indicated by the OD600
value. The reaction mixtures were incubated at 37 °C for
the production of GABA.
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Statistical analysis

Assays were conducted in triplicate and values were
expressed as the mean ± standard deviation. Thereafter, one-way analysis of variance and subsequent
Tukey-Kramer multiple-comparison tests were
conducted to evaluate the significance of differences
(p < 0.05).
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